These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15787543)

  • 1. Synthesis of 5-substituted-1H-indol-2-yl-1H-quinolin-2-ones: a novel class of KDR kinase inhibitors.
    Kuethe JT; Wong A; Qu C; Smitrovich J; Davies IW; Hughes DL
    J Org Chem; 2005 Apr; 70(7):2555-67. PubMed ID: 15787543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel KDR kinase inhibitors through catalytic reductive cyclization of o-nitrobenzylcarbonyl compounds.
    Wong A; Kuethe JT; Davies IW; Hughes DL
    J Org Chem; 2004 Oct; 69(22):7761-4. PubMed ID: 15498012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and efficient synthesis of 1H-indol-2-yl-1H-quinolin-2-ones.
    Kuethe JT; Wong A; Davies IW
    Org Lett; 2003 Oct; 5(21):3975-8. PubMed ID: 14535757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient syntheses of KDR kinase inhibitors using a Pd-catalyzed tandem C-N/Suzuki coupling as the key step.
    Fang YQ; Karisch R; Lautens M
    J Org Chem; 2007 Feb; 72(4):1341-6. PubMed ID: 17253753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors.
    Han SY; Choi JW; Yang J; Chae CH; Lee J; Jung H; Lee K; Ha JD; Kim HR; Cho SY
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2837-42. PubMed ID: 22450128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microwave-assisted multistep synthesis of functionalized 4-arylquinolin-2(1H)-ones using palladium-catalyzed cross-coupling chemistry.
    Glasnov TN; Stadlbauer W; Kappe CO
    J Org Chem; 2005 May; 70(10):3864-70. PubMed ID: 15876072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity-oriented synthesis of functionalized quinolin-2(1H)-ones via Pd-catalyzed site-selective cross-coupling reactions.
    Wang Z; Wang B; Wu J
    J Comb Chem; 2007; 9(5):811-7. PubMed ID: 17691746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoindolinone ureas: a novel class of KDR kinase inhibitors.
    Curtin ML; Frey RR; Heyman HR; Sarris KA; Steinman DH; Holmes JH; Bousquet PF; Cunha GA; Moskey MD; Ahmed AA; Pease LJ; Glaser KB; Stewart KD; Davidsen SK; Michaelides MR
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4505-9. PubMed ID: 15357981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor.
    Kinose F; Roscilli G; Lamartina S; Anderson KD; Bonelli F; Spence SG; Ciliberto G; Vogt TF; Holder DJ; Toniatti C; Thut CJ
    Mol Vis; 2005 May; 11():366-73. PubMed ID: 15951738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase.
    Bilodeau MT; Rodman LD; McGaughey GB; Coll KE; Koester TJ; Hoffman WF; Hungate RW; Kendall RL; McFall RC; Rickert KW; Rutledge RZ; Thomas KA
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2941-5. PubMed ID: 15125964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and SAR of 1,9-dihydro-9-hydroxypyrazolo[3,4-b]quinolin-4-ones as novel, selective c-Jun N-terminal kinase inhibitors.
    Liu M; Xin Z; Clampit JE; Wang S; Gum RJ; Haasch DL; Trevillyan JM; Abad-Zapatero C; Fry EH; Sham HL; Liu G
    Bioorg Med Chem Lett; 2006 May; 16(10):2590-4. PubMed ID: 16527482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotype.
    Cano C; Barbeau OR; Bailey C; Cockcroft XL; Curtin NJ; Duggan H; Frigerio M; Golding BT; Hardcastle IR; Hummersone MG; Knights C; Menear KA; Newell DR; Richardson CJ; Smith GC; Spittle B; Griffin RJ
    J Med Chem; 2010 Dec; 53(24):8498-507. PubMed ID: 21080722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDR.
    Wu Z; Fraley ME; Bilodeau MT; Kaufman ML; Tasber ES; Balitza AE; Hartman GD; Coll KE; Rickert K; Shipman J; Shi B; Sepp-Lorenzino L; Thomas KA
    Bioorg Med Chem Lett; 2004 Feb; 14(4):909-12. PubMed ID: 15012992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KDR inhibitor with the intramolecular non-bonded interaction: conformation-activity relationships of novel indole-3-carboxamide derivatives.
    Honda T; Nagahara H; Mogi H; Ban M; Aono H
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1782-5. PubMed ID: 21324683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,2,3-Thiadiazole substituted pyrazolones as potent KDR/VEGFR-2 kinase inhibitors.
    Tripathy R; Ghose A; Singh J; Bacon ER; Angeles TS; Yang SX; Albom MS; Aimone LD; Herman JL; Mallamo JP
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1793-8. PubMed ID: 17239587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of substituted 3-anilino-quinolin-2(1H)-ones as PDK1 inhibitors.
    O'Brien NJ; Brzozowski M; Wilson DJ; Deady LW; Abbott BM
    Bioorg Med Chem; 2014 Jul; 22(14):3781-90. PubMed ID: 24856302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel 1,2,3,4-tetrahydroisoquinolines and 3,4-dihydroisoquinoline-1(2H)-ones as potent and selective inhibitors of KDR: synthesis, SAR, and pharmacokinetic properties.
    Choquette D; Teffera Y; Polverino A; Harmange JC
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4054-8. PubMed ID: 18573658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transition metal mediated construction of pyrrole ring on 2,3-dihydroquinolin-4(1H)-one: synthesis and pharmacological evaluation of novel tricyclic heteroarenes.
    Layek M; Reddy M A; Rao AV; Alvala M; Arunasree MK; Islam A; Mukkanti K; Iqbal J; Pal M
    Org Biomol Chem; 2011 Feb; 9(4):1004-7. PubMed ID: 21180745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-guided identification of novel VEGFR-2 kinase inhibitors via solution phase parallel synthesis.
    Tripathy R; Reiboldt A; Messina PA; Iqbal M; Singh J; Bacon ER; Angeles TS; Yang SX; Albom MS; Robinson C; Chang H; Ruggeri BA; Mallamo JP
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2158-62. PubMed ID: 16460933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrimido[4,5-c]quinolin-1(2H)-ones as a novel class of antimitotic agents: Synthesis and in vitro cytotoxic activity.
    Metwally K; Pratsinis H; Kletsas D
    Eur J Med Chem; 2007 Mar; 42(3):344-50. PubMed ID: 17141923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.